as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
5.70%
Downside
3.11%
Upside
52 Week's Low
52 Week's High
45.60%
Downside
164.25%
Upside
Check Climb Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$132.1M
EPS (TTM)
-0.75
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
323100.00%
Compare market cap, revenue, PE, and other key metrics of Climb Bio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $132.1M | NA | NA | 0.00% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Climb Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Climb Bio Inc investment value today
Current value as on today
₹43,241
Returns
Returns from Climb Bio Inc Stock
Dollar Returns*
₹4,794 (+4.79%)
Search interest for Climb Bio Inc Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:30% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 124.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 194.3%
Price Dip
In the last 1 year, CLYM stock has moved down by -61.6%
Organisation | Climb Bio Inc |
Headquarters | 20 William Street, Wellesley Hills, MA, United States, 02481 |
CEO | Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Kate Hecht M.B.A. | Senior Vice President of Program Management |
Dr. Perrin Wilson B.S., Ph.D. | Chief Business Officer |
Dr. Edgar D. Charles M.D., M.Sc. | Chief Medical Officer |
Ms. Cindy J. Driscoll M.B.A. | Senior Vice President of Finance |
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc | CEO, President & Director |
Dr. Susan Altschuller M.B.A., Ph.D. | Chief Financial Officer |
Ms. Chandra Adams J.D. | VP & General Counsel |
Ms. Janaki M. Subramanyam M.Sc. | VP & Head of Regulatory Affairs |
Climb Bio Inc share price today is $1.93 as on at the close of the market. Climb Bio Inc share today touched a day high of $1.99 and a low of $1.82.
Climb Bio Inc share touched a 52 week high of $5.1 on and a 52 week low of $1.05 on . Climb Bio Inc stock price today i.e. is closed at $1.93,which is 62.16% down from its 52 week high and 83.81% up from its 52 week low.
Climb Bio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Climb Bio Inc (CLYM) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Climb Bio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Climb Bio Inc share’s latest price of $1.93 as on October 18, 2025 at 1:29 am IST, you will get 5.1813 shares of Climb Bio Inc. Learn more about
fractional shares .